Phenotox was founded by James Sidaway in 2014 with the objective of developing novel science concepts and technical solutions that enable animal-free toxicology and optimal safety assessment.

James has worked in the pharmaceutical industry for over 25 years applying innovative molecular and cellular technologies to drug safety issues across the drug discovery and development pipeline.  In this time, he also gained broad experience of informatics and in silico toxicology approaches.   In March 2021 , James joined Apconix as Target Safety Assessment Discipline Lead.